Healthcare at Home acquires Sciensus

- Acquisition Brings Sophisticated Healthcare Data Capture and Reporting Capabilities

Healthcare at Home Ltd (http://www.hah.co.uk), Europe's leading international provider of home-based healthcare and specialty pharmacy services, is today pleased to announce that it has acquired Sciensus Ltd, a provider of health informatics for clients across the NHS and the pharmaceutical industry.

Health informatics is an area of worldwide growth potential as governments seek to optimise the value from healthcare spending, and pharmaceutical companies are asked to demonstrate greater clinical and cost effectiveness for the products they produce. The data currently gathered by Sciensus about how treatments work in "real life" settings, rather than in clinical trials alone, is therefore of immense value to all involved in patient-centric health provision. The Sciensus acquisition enables Healthcare at Home to provide sophisticated data capture and reporting systems for its clients, alongside existing home drug delivery and clinical care services.

Sciensus will continue to operate independently with its current management team in order to ensure absolute focus on customer requirements and integrity on matters relating to information governance. Healthcare at Home will work with Sciensus to maximise the visibility, value and effect of the clinical services it can offer. The information regarding treatment and service outcomes will generate even greater insight and evidence to support the case for treating patients outside of the traditional hospital setting. Financial terms were not disclosed.

Mike Gordon, Chief Executive Officer of Healthcare at Home, commented: "With the NHS and pharmaceutical sector seeking greater measures of the efficiency and effectiveness of their interventions, the acquisition of Sciensus gives Healthcare at Home industry-leading expertise with which to help our customers achieve this goal."

Healthcare at Home delivers a wide range of clinical services across many therapeutic areas to more than 100,000 patients each year, working in partnership with the NHS, private medical insurers, pharmaceutical companies, charities, and self-funding patients. The company's convenient and innovative services are highly rated by patients and referring clinicians, and deliver cost-effective solutions for healthcare commissioners.

By working with patients, and their families, to keep them out of hospital, Healthcare at Home provides services that enable patients to lead more independent lives by providing them with high quality care when they need it and where they want it. Healthcare at Home provides a full service home healthcare approach, offering services such as chemotherapy at home, paediatric care and the provision of emotional and clinical support by fully trained nursing staff.

SOURCE Healthcare at Home Ltd